Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2019; Volume 95,Issue 1

Minireview

  • You have access
    Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo–Steady-State Responses from GABAA Receptors
    Joe Henry Steinbach and Gustav Akk
    Molecular Pharmacology January 2019, 95 (1) 106-119; DOI: https://doi.org/10.1124/mol.118.113787

Articles

  • You have access
    Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate β-Arrestin–Dependent Responses
    Caitlin A. D. Jagla, Caitlin E. Scott, Yaliang Tang, Changjiang Qiao, Gabriel E. Mateo-Semidey, Guillermo A. Yudowski, Dai Lu and Debra A. Kendall
    Molecular Pharmacology January 2019, 95 (1) 1-10; DOI: https://doi.org/10.1124/mol.118.112854
  • You have access
    Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine
    Wakako Fujita, Mini Yokote, Ivone Gomes, Achla Gupta, Hiroshi Ueda and Lakshmi A. Devi
    Molecular Pharmacology January 2019, 95 (1) 11-19; DOI: https://doi.org/10.1124/mol.118.112987
  • You have access
    Subcellular Localization and Activity of the Mitogen-Activated Protein Kinase Kinase 7 (MKK7) γ Isoform are Regulated through Binding to the Phosphatase Calcineurin
    Emily S. Gibson, Kevin M. Woolfrey, Huiming Li, Patrick G. Hogan, Raphael A. Nemenoff, Lynn E. Heasley and Mark L. Dell’Acqua
    Molecular Pharmacology January 2019, 95 (1) 20-32; DOI: https://doi.org/10.1124/mol.118.113159
  • Open Access
    Substrate-Induced Motion between TM4 and TM7 of the Glutamate Transporter EAAT1 Revealed by Paired Cysteine Mutagenesis
    Wenlong Zhang, Xiuping Zhang and Shaogang Qu
    Molecular Pharmacology January 2019, 95 (1) 33-42; DOI: https://doi.org/10.1124/mol.118.113183
  • You have access
    Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107
    Marta Quadri, Sumanta Garai, Ganesh A. Thakur, Clare Stokes, Alican Gulsevin, Nicole A. Horenstein and Roger L. Papke
    Molecular Pharmacology January 2019, 95 (1) 43-61; DOI: https://doi.org/10.1124/mol.118.113340
  • Open Access
    N-Phthalyl-l-Tryptophan (RG108), like Clozapine (CLO), Induces Chromatin Remodeling in Brains of Prenatally Stressed Mice
    Erbo Dong, Valentina Locci, Eleonora Gatta, Dennis R. Grayson and Alessandro Guidotti
    Molecular Pharmacology January 2019, 95 (1) 62-69; DOI: https://doi.org/10.1124/mol.118.113415
  • You have access
    Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites
    Daniel J. Shin, Allison L. Germann, Douglas F. Covey, Joe Henry Steinbach and Gustav Akk
    Molecular Pharmacology January 2019, 95 (1) 70-81; DOI: https://doi.org/10.1124/mol.118.113464
  • You have access
    A Modified Tripeptide Motif of RS1 (RSC1A1) Down-Regulates Exocytotic Pathways of Human Na+-d-glucose Cotransporters SGLT1, SGLT2, and Glucose Sensor SGLT3 in the Presence of Glucose
    Nadine Schäfer, Prashanth Reddy Rikkala, Maike Veyhl-Wichmann, Thorsten Keller, Christian Ferdinand Jurowich, Dietmar Geiger and Hermann Koepsell
    Molecular Pharmacology January 2019, 95 (1) 82-96; DOI: https://doi.org/10.1124/mol.118.113514
  • Open Access
    Constitutive Androstane Receptor 1 is Constitutively Bound to Chromatin and 'Primed' for Transactivation in Hepatocytes
    Michael McMahon, Shaohong Ding, Lourdes Acosta Jimenez, Remi Terranova, Marie-Apolline Gerard, Antonio Vitobello, Jonathan Moggs, Colin J. Henderson and C. Roland Wolf
    Molecular Pharmacology January 2019, 95 (1) 97-105; DOI: https://doi.org/10.1124/mol.118.113555
  • You have access
    Cell Cycle and Apoptosis Regulator 1, CCAR1, Regulates Enhancer-Dependent Nuclear Receptor CAR Transactivation
    Yuichiro Kanno, Shuai Zhao, Naoya Yamashita, Nao Saito, Aoi Ujiie, Rie Iijima, Nami Kikawa, Kiyomitsu Nemoto and Yoshio Inouye
    Molecular Pharmacology January 2019, 95 (1) 120-126; DOI: https://doi.org/10.1124/mol.118.114272
  • You have access
    Lysosome Membrane Permeabilization and Disruption of the Molecular Target of Rapamycin (mTOR)-Lysosome Interaction Are Associated with the Inhibition of Lung Cancer Cell Proliferation by a Chloroquinoline Analog
    Juan Sironi, Evelyn Aranda, Lars Ulrik Nordstrøm and Edward L. Schwartz
    Molecular Pharmacology January 2019, 95 (1) 127-138; DOI: https://doi.org/10.1124/mol.118.113118
  • You have access
    Identification of Peracetylated Quercetin as a Selective 12-Lipoxygenase Pathway Inhibitor in Human Platelets
    Marco S. Doucet, Jean-Luc Jougleux, Samuel J. Poirier, Marc Cormier, Jacob L. Léger, Marc E. Surette, Nicolas Pichaud, Mohamed Touaibia and Luc H. Boudreau
    Molecular Pharmacology January 2019, 95 (1) 139-150; DOI: https://doi.org/10.1124/mol.118.113480
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 95 (1)
Molecular Pharmacology
Vol. 95, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics